Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review

Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review

Background: Prostate-specific membrane antigen (PSMA) is not sufficiently overexpressed in a small proportion of prostate cancer (PCa) patients, who require other strategies for imaging and/or treatment. We reviewed potential targets other than PSMA for PCa theranostics in nuclear medicine that have...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mathieu Gauthé, Paul Sargos, Eric Barret, Gaëlle Fromont-Hankard, Jean-Baptiste Beauval, Laurent Brureau, Gilles Créhange, Raphaële Renard-Penna, Charles Dariane, Gaëlle Fiard, Romain Mathieu, Guilhem Roubaud, Alain Ruffion, Morgan Rouprêt, Guillaume Ploussard, on behalf of the CC-AFU
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
nuclear medicine
therapeutics
molecular imaging
Medicine
R
Accès en ligne:https://doaj.org/article/8988e2088a0847deb5a3abe8920cc3f5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/8988e2088a0847deb5a3abe8920cc3f5

Documents similaires